Companies: 10,795·Total market cap: $144.5T
Allakos Inc.

Allakos Inc.

ALLKNASDAQHealthcare
$0.33
+$0.00(+0.22%)
Market Cap$29743071
P/E Ratio—
52W High$1.56
52W Low$0.22
Overview

Allakos Inc. (ALLK) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001564824 · ALLK · NASDAQ · as of Jun 9, 2026

Filing snapshot

548
Total Filings
SCHEDULE 13G/A
Latest Form
2025-08-14
Most Recent
2018
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001564824 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2025-04-17
Fiscal Year End
Apr 17, 2025
Accession No.
0000950170-25-055357
Primary Document
allk-20241231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001564824 · Accession 0000950170-25-055357

Latest Key Filings

10-QQuarterly Report
10-Q
2025-05-07
View 10-Q on SEC
8-KCurrent Report
8-K
2025-05-15Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2025-08-14
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2025-08-14
View
15-12G15-12G
15-12G
2025-05-27
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2025-05-19
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2025-05-19
View
EFFECTEFFECT
EFFECT
2025-05-16
View
EFFECTEFFECT
EFFECT
2025-05-16
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2025-05-16
View
S-8 POSS-8 POS
S-8 POS
2025-05-15
View
S-8 POSS-8 POS
S-8 POS
2025-05-15
View
S-8 POSS-8 POS
S-8 POS
2025-05-15
View
S-8 POSS-8 POS
S-8 POS
2025-05-15
View
S-8 POSS-8 POS
S-8 POS
2025-05-15
View
S-8 POSS-8 POS
S-8 POS
2025-05-15
View
S-8 POSS-8 POS
S-8 POS
2025-05-15
View
Showing 1–15 of 321 filingsForm 4 / 144 hidden· 548 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001564824  |  Exchange: NASDAQ · Healthcare

Allakos Inc. (NASDAQ: ALLK) has submitted 548 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2018. As a Healthcare sector company with CIK 0001564824, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Allakos Inc.'s most comprehensive regulatory disclosure. The most recent Allakos Inc. 10-K was filed on 2025-04-17 for fiscal year ending 2025. Historical ALLK 10-K annual reports are available from 2012 through 2025.

Investors researching Allakos Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
ODTC SEC Filings →HARP SEC Filings →MRNS SEC Filings →ANGN SEC Filings →FRLN SEC Filings →ELEV SEC Filings →LIANY SEC Filings →KA SEC Filings →
→ ALLK Financials→ ALLK Earnings→ ALLK Insider Trades

Frequently Asked Questions

ALLK SEC Filings · 8 questions

Allakos Inc. (ALLK) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 548 filings and access original documents at no cost. Allakos Inc.'s CIK is 0001564824.

ALLK SEC filingsAllakos Inc. SEC documentsfind ALLK 10-K